Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Heart disease is responsible for about one-fourth of all deaths in India, and a fair share of these are caused by deaths occurring among women ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

Popular medications approved for weight loss, diabetes, and heart disease may have health benefits beyond weight loss, and blood sugar control, but there are risks too.

Neglecting high blood pressure can increase the risk of a very serious disease. High blood pressure doesn’t just affect your ...

However, the benefits of beta-blockers in “stiff heart” heart failure are less clear. This condition, also known as heart ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

About half of U.S. adults have high blood pressure, a major risk for heart attacks, strokes, kidney failure, even dementia.

Taken at face value, the results would suggest that the three SGLT2 inhibitors are "virtually identical," according to ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...